Personal information

Activities

Funding (12)

Pursuing targeted protein degradation as a new strategy for antituberculosis drug development

2024-01 to 2026-12 | Grant
Bill & Melinda Gates Foundation (Seattle, US)
Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Research and development of a novel natural product based non-hormonal female contraceptive

2024-01 to 2025-12 | Grant
Bill & Melinda Gates Foundation (Seattle, US)
Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Research and development of a novel natural product based oral female sterilizing contraceptive

2022-03 to 2024-02 | Grant
Kenya Medical Research Institute (Nairobi, KE)
Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Assessment of novel natural product drug combinations for the treatment of multidrug-resistant and extensively drug-resistant TB

2021-07 to 2022-06 | Grant
Medical Research Foundation (Bristol, GB)
Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Identification of novel synthetic and natural products derivatives targeting Mycobacterium tuberculosis bedaquiline/clofazimine/doxycycline efflux pumps

2021-04 to 2023-03 | Grant
Grand Challenges Africa through Alliance for Accelerating Excellence in Science in Africa (AESA) (Nairobi, KE)
Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Documentation, Pre-Clinical Evaluation and Prototype Development of Natural Products or in Combinations with Hydroxychloroquine for Prevention and Management of Covid-19

2020-08 to 2022-05 | Grant
Kenya Medical Research Institute (KEMRI), Internal Research Grants (Nairobi, KE)
Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Isolation, characterization and bioactivity evaluation of phytochemicals from selected medicinal plants of Fabaceae family against Mycobacterium tuberculosis.

2020-07 to 2022-06 | Grant
International Foundation for Science (Stockholm , SE)
Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Antifertility Evaluation of Bioactive Compounds from Selected Kenyan Medicinal Plants

2019-11 to 2022-10 | Grant
National Research Fund, Kenya (Nairobi, KE)
Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Evaluation of anticancer, antidiabetic, phytochemical and safety properties of formulated herbal remedies being marketed in selected counties of Kenya

2019-01 to 2021-12 | Grant
Kenya Medical Research Institute (KEMRI), Internal Research Grants (Nairobi, KE)
Part of GRANT_NUMBER:

KEMRI/CONF/FIN/6/101

Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

An Investigation of anti-TB properties against Mycobacterium tuberculosis, of extracts and compounds derived from Kenyan medicinal plants, in combination with anti-TB drugs, for development of an antimycobacterial regimen

2018-01 to 2020-12 | Grant
The World Academy of Sciences (Trieste, IT)
GRANT_NUMBER:

17-359 RG/CHE/AF/AC_I – FR3240297746

Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Immune enhancing potentials of Moringa oleifera nutritional supplement in treatment of HIV/AIDS

2016-04 to 2019-06 | Grant
National Research Fund (Nairobi, KE)
Part of GRANT_NUMBER:

DVCR/NRF/VOL.1/85

Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Holistic assessment of malaria in Kirinyaga County: Evaluation of antimalarial drugs quality insecticide treated nets and improvement of diagnosis

2016-03 to 2019-12 | Grant
Kenyan Government (Nairobi, KE)
Part of GRANT_NUMBER:

KEMRI/CONF/FIN/6/101

Source: Self-asserted source
Elizabeth V. Mumbi Kigondu

Peer review (1 review for 1 publication/grant)

Review activity for International journal of tropical insect science. (1)